Tag: Alzheimer’s
Cognito presents MRI data showing efficacy of non-invasive gamma stimulation therapy...
Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation...
Deep brain stimulation may fulfil “desperate need” for effective Alzheimer’s therapy
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients...
London clinic becomes first in UK to offer new drug-free Alzheimer’s...
The London Alzheimer’s Clinic on Harley Street (London, UK) has become the first clinic in the UK to offer transcranial pulse stimulation (TPS)—a “revolutionary”...
Sonocloud technology demonstrates safety and therapeutic potential in Alzheimer’s patients
Carthera has announced today the publication of results from an investigator-sponsored pilot clinical trial evaluating safety and efficacy using its Sonocloud technology in patients...
Intermittent theta-burst stimulation found to be effective and well-tolerated in Alzheimer’s...
The findings of a randomised controlled trial (RCT) have indicated that accelerated intermittent theta-burst stimulation (iTBS), administered to the left dorsolateral prefrontal cortex (DLPFC), is an...
Intranasal delivery of microrobots could trigger new possibilities in treating neurological...
A research team in South Korea has developed and successfully implanted a microrobot device into the brain tissue of mice through the intranasal pathway,...
Study indicates efficacy of hyperbaric oxygen therapy in reversing Alzheimer’s activators
A new study, published in the peer-reviewed medical journal Aging, marks the first time non-pharmaceutical clinical exploration has proved efficacious in reversing the main...
BioArctic receives European patent for antibodies targeting Alzheimer’s disease
BioArctic AB has announced that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for...
VeraSci partners with ActiGraph for wearables clinical trial monitoring Alzheimer’s decline
VeraSci has announced a partnership with ActiGraph, to expand the use of wearables in clinical trials.
According to a company press release, VeraSci's Innovation Lab...
Brain injury may boost risk of Alzheimer’s earlier in life
Concussions and other traumatic brain injuries may increase the risk of developing Alzheimer’s disease earlier in life, according to a study published in Neuropsychology.
The...
Deep brain stimulation shows promise as treatment for Alzheimer’s disease
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and...
Transcranial magnetic stimulation may improve accuracy of Alzheimer’s disease diagnosis
Transcranial magnetic stimulation (TMS) may help determine whether a person has Alzheimer’s disease or frontotemporal dementia, according to a preliminary study published in Neurology.
“Making the...
Sleep problems may be early sign of Alzheimer’s
Poor sleep may be a sign that people who are otherwise healthy may be more at risk of developing Alzheimer’s disease later in life...
Longeveron begins enrolment of second cohort of trial of stem cell...
Longeveron has announced that their Phase 1 Alzheimer's disease trial will proceed with enrolment at the recommendation of an independent Data Monitoring Committee (DMC)...
First study of diet’s impact on dementia, Alzheimer’s disease, begins
The first study of its kind designed to test the effects of a diet on the decline of cognitive abilities among a large group...
Study links cerebrovascular disease to Alzheimer’s
Diseased blood vessels in the brain itself may contribute more significantly to Alzheimer's disease dementia than was previously believed, according to new study results...
